JoachimYahalomMDFASTRO

Professor of Radiation Oncology, Cornell University-Weill Medical College

Overview of Dr. Yahalom

Dr. Joachim Yahalom is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from The Hebrew University of Jerusalem Hadassah Medical School and has been in practice 44 years. Dr. Yahalom accepts several types of health insurance, listed below. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 76 doctors at New York-Presbyterian Hospital who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(323) 238-8363

Education & Training

The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1973

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 1986 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
New York Magazine: Top Doctors Castle Connolly, 2005-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Start of enrollment: 1998 Aug 01
Completed
Phase 2
Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type Start of enrollment: 2018 Nov 09
Active, not recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal.
Gustav Y Cederquist, Kathryn Tringale, Joachim Yahalom, Brandon S Imber
Seminars in Radiation Oncology. 2025-01-01
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma.
Kathryn R Tringale, Michael Scordo, Joachim Yahalom, Charlie White, Zhigang Zhang
Blood Advances. 2024-12-24
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.
Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2024-12-11

Abstracts/Posters

Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Sal...
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Should a Bulky Mediastinal Mass _7cm in the Longest Dimension be Considered an Adverse Prognostic Factor in Patients with Advanced Hodgkin Lymphoma and Negative Interi...
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Joachim Yahalom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Other

Initial treatment of advanced (stage III-IV) classical Hodgkin lymphoma
Yahalom J, Horwitz S
http://www.uptodate.com/contents/initial-treatment-of-advanced-stage-iii-iv-classical-hodgkin-lympho
UpToDate, Wolters Kluwer Health - 2013-02-25
Management of classical Hodgkin lymphoma during pregnancy
Yahalom J, Horwitz S
http://www.uptodate.com/contents/management-of-classical-hodgkin-lymphoma-during-pregnancy
UpToDate, Wolters Kluwer Health - 2012-06-19

Press Mentions

Structure of mRNA Initiation Complex Could Give Insight into Cancer and Other DiseasesSeptember 3rd, 2020
CT and MRI Interactive Atlas of Cross-Sectional Anatomy Download Free Direct Link Torrent by 4realtorrentzCT and MRI InDecember 2nd, 2016

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
PriorityHealth HMO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment